Stock 301263 GUANGDONG TAIENKANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Guangdong Taienkang Pharmaceutical Co., Ltd.

Equities

301263

CNE1000058X0

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
13.75 CNY +0.88% Intraday chart for Guangdong Taienkang Pharmaceutical Co., Ltd. -2.69% -15.80%
04-22 Guangdong Taienkang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-22 Guangdong Taienkang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Guangdong Taienkang Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development and production of pharmaceutical products. The Company's businesses include agency operation, and sales of pharmaceutical products, medical devices and hygiene materials. The Company's main products include chemical medicines, external medicines, proprietary Chinese medicines, medical devices and hygiene materials. The Company is also engaged in the provision of medical technology services and technology transfer. The Company mainly conducts its businesses in the domestic market.

Number of employees: 931

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Agent
56.6 %
388 49.5 % 430 56.6 % +10.97%
Pharmaceutical Manufacturing
42.7 %
361 46.1 % 325 42.7 % -9.93%
Medical Technology Services
0.6 %
34 4.4 % 5 0.6 % -86.08%
Other
0.1 %
1 0.1 % 1 0.1 % +4.59%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
783 100.0 % 761 100.0 % -2.88%
Abroad
0.0 %
0 0.0 % 0 0.0 % -87.60%

Managers

Managers TitleAgeSince
Han Jie Zheng CEO
 Chief Executive Officer 61 98-12-31
Gui Xi Zhou DFI
 Director of Finance/CFO 37 22-12-01
Ting Li BRD
 Director/Board Member 41 19-11-30
Chun Chen BRD
 Director/Board Member 61 99-12-31

Members of the board

Members of the board TitleAgeSince
Ying Liang BRD
 Director/Board Member 52 22-06-29
Yi Ping Rui BRD
 Director/Board Member 70 18-02-02
Han Jie Zheng CEO
 Chief Executive Officer 61 98-12-31
Wei Wen Sun BRD
 Director/Board Member 57 98-12-31
Chun Chen BRD
 Director/Board Member 61 99-12-31
Ting Li BRD
 Director/Board Member 41 19-11-30
Zhi Wei Fang BRD
 Director/Board Member 52 18-02-02
Mu Qiang Zheng BRD
 Director/Board Member 43 20-07-22
Zi Li Lin CHM
 Chairman 48 00-06-30
Jian Xin Wang BRD
 Director/Board Member 46 98-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 425,497,500 189,855,917 ( 44.62 %) 1,985,118 ( 0.4665 %) 44.62 %

Shareholders

NameEquities%Valuation
Zhangshu Huabo Jingcheng Investment Management Center LP
9.247 %
21,175,521 9.247 % 42 M ¥
Chao Yi Zhang
4.939 %
11,311,200 4.939 % 22 M ¥
Wei Shan Huang
4.913 %
11,251,800 4.913 % 22 M ¥
GTJA Junxiang GEM Taienkang Term 1 Collective Asset Mgmt Plan
4.272 %
9,783,040 4.272 % 19 M ¥
Shenzhen Nalanda Investment Fund Management Co. Ltd.
3.183 %
7,290,184 3.183 % 14 M ¥
Baoying Fund Management Co., Ltd.
2.394 %
5,482,707 2.394 % 11 M ¥
Yang Xu
1.916 %
4,387,500 1.916 % 9 M ¥
China Asset Management Co., Ltd.
1.913 %
4,379,945 1.913 % 9 M ¥
Guotai Asset Management Co., Ltd.
1.871 %
4,285,230 1.871 % 8 M ¥
Beijing Lianchuang Beituo Investment Holdings Co. Ltd.
1.825 %
4,179,600 1.825 % 8 M ¥

Company contact information

Guangdong Taienkang Pharmaceutical Co., Ltd.

Block A, 8 Wanji South 2nd Street Taishan North Road

515041, Shantou

+

http://www.tai-kang.com.cn
address Guangdong Taienkang Pharmaceutical Co., Ltd.(301263)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Guangdong Taienkang Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13.75
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GUANGDONG TAIENKANG PHARMACEUTICAL CO., LTD. Stock Guangdong Taienkang Pharmaceutical Co., Ltd.
-15.80% 804M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
NOVARTIS AG Stock Novartis AG
+9.78% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301263 Stock
  4. Company Guangdong Taienkang Pharmaceutical Co., Ltd.